CDK12 as a Potential Biomarker for Characterization of Circulating Tumor Cells in Epithelial Ovarian Tumors
Hence, the study demonstrated the potential of CDK12 as a biomarker for future blood-based diagnosis and personalized treatment in epithelial ovarian tumor patients.
Authors
- Zeba Haque (ORCID: https://orcid.org/0000-0001-6915-5113)
- Jahan Ara Hasan (ORCID: https://orcid.org/0000-0003-2010-466X)
- Nazia Ahmed (ORCID: https://orcid.org/0000-0001-9436-3280)
- Waqas Ahmed Farooqui (ORCID: https://orcid.org/0000-0002-8773-8029)
- Seema B. Jabbar (ORCID: https://orcid.org/0009-0004-9704-1657)
Institutions
- Dow University of Health Sciences (PK)
Publication Details
- Journal
- Current Molecular Medicine
- Published
- 2025-10-29
- DOI
- https://doi.org/10.2174/0115665240419560251019165333
- Primary Topic
- Ovarian cancer diagnosis and treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00